These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunologic surface markers in non-Hodgkin's lymphomas. Cossman J, Schnitzer B, Deegan MJ. Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504 [Abstract] [Full Text] [Related]
5. Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. Jaffe ES, Shevach EM, Sussman EH, Frank M, Green I, Berard CW. Br J Cancer Suppl; 1975 Mar; 2():107-20. PubMed ID: 1081000 [Abstract] [Full Text] [Related]
6. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant. Treetipsatit J, Metcalf RA, Warnke RA, Natkunam Y. Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392 [Abstract] [Full Text] [Related]
8. Malignant lymphomas as tumours of the immune system. Berard CW, Cossman J, Jaffe ES. Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112 [Abstract] [Full Text] [Related]
9. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Brouet JC, Labaume S, Seligmann M. Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001 [Abstract] [Full Text] [Related]
10. Non-Hodgkin's lymphomas: an immunohistochemical and histological study. Curran RC, Jones EL. J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105 [Abstract] [Full Text] [Related]
11. Differentiation between benign and malignant human lymph nodes by means of immunologic markers. Brubaker DB, Whiteside TL. Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086 [Abstract] [Full Text] [Related]
12. Coexistence of two lymphomas with distinctive histologic, ultrastructural, and immunologic features. Cossman J, Schnitzer B, Deegan MJ. Am J Clin Pathol; 1978 Sep; 70(3):409-15. PubMed ID: 360821 [Abstract] [Full Text] [Related]